Norris Medicines has informed that it enclosed a certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the period 01st January, 2022 to 31st March, 2022, received from PurvaSharegistry (I), Registrar and Share Transfer Agent of the Company.
The above information is a part of company’s filings submitted to BSE.